Darell Bigner
Clinical trials sponsored by Darell Bigner, explained in plain language.
-
Direct-to-Brain attack: new combo targets deadly recurrent tumor
Disease control Recruiting nowThis early-stage study is testing the safety and effectiveness of a two-part immunotherapy for adults whose aggressive brain cancer (glioblastoma) has returned after initial treatment. After surgery to remove the main tumor, a special combination of two drugs is delivered directl…
Phase: PHASE1 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Apr 01, 2026 21:56 UTC
-
New brain cancer treatment aims to train immune system to fight tumors
Disease control Recruiting nowThis study is testing a new two-drug immunotherapy for adults newly diagnosed with a specific, aggressive type of brain cancer called MGMT unmethylated glioblastoma. The goal is to see if it is safe and can help patients live longer. The treatment involves placing a drug directly…
Phase: PHASE1, PHASE2 • Sponsor: Darell Bigner • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC